An open-label study of patients with major depressive disorder found that psilocybin treatment led to increased cognitive flexibility (measured by perseverative errors on a set-shifting task) and neural flexibility (measured by functional connectivity via fMRI) that persisted for up to four weeks post-treatment.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (4)

• psilocybin concept
• Major Depressive Disorder concept
• Functional MRI concept
• Cognitive Flexibility concept